Connection

Wu Zhong to Drug Design

This is a "connection" page, showing publications Wu Zhong has written about Drug Design.
Connection Strength

0.995
  1. Design, synthesis and biological evaluation of 2-hydrazinyladenosine derivatives as A2A adenosine receptor ligands. Eur J Med Chem. 2019 Oct 01; 179:310-324.
    View in: PubMed
    Score: 0.325
  2. Design, synthesis and pharmacological evaluation of a novel mTOR-targeted anti-EV71 agent. Eur J Med Chem. 2019 Aug 01; 175:172-186.
    View in: PubMed
    Score: 0.321
  3. Design and synthesis of piperidine derivatives as novel human heat shock protein 70 inhibitors for the treatment of drug-resistant tumors. Eur J Med Chem. 2015 Jun 05; 97:19-31.
    View in: PubMed
    Score: 0.243
  4. Design, synthesis and in vitro anti-Zika virus evaluation of novel Sinefungin derivatives. Eur J Med Chem. 2018 Sep 05; 157:994-1004.
    View in: PubMed
    Score: 0.077
  5. Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload. Int J Mol Sci. 2017 Aug 25; 18(9).
    View in: PubMed
    Score: 0.018
  6. Novel immunomodulators based on an oxazolin-2-one-4-carboxamide scaffold. Bioorg Med Chem Lett. 2012 Jan 01; 22(1):553-7.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.